Therapeutic Candidate or Device Allogeneic human retinal progenitor cells (hRPC) Indication Retinitis Pigmentosa (RP) Therapeutic Mechanism The cells are intended to remain suspended in the vitreous cavity of the eye…
Therapeutic Candidate or Device The therapeutic candidate is a patient specific (autologous) induced pluripotent stem cell derived retinal pigment epithelium (AiPSC-RPE) product. Indication AiPSC-RPE cell product will be indicated for…
Therapeutic Candidate or Device cultivated patient-specific corneal epithelial stem cells (limblal stem cells, LSC) Indication Corneal blindness from inability to heal due to corneal epithelial stem cell deficiency as a…
Therapeutic Candidate or Device human fetal cortex derived neural progenitor cells (CNS10-NPC) Indication To stabilize disease progression and maintain ocular integrity and vision for RP patients. This approach can be…
Rosie Barrero has been steadily losing her vision since childhood due to retinitis pigmentosa (RP), an inherited, incurable disease. In 2016, she volunteered for a CIRM-funded clinical trial testing the…
Stem Cells in Your Face, Episode 3: Eyeing Stem Cell Therapies for Vision Loss. Written and narrated by Kevin McCormack. Directed and edited by Todd Dubnicoff. Eye anatomy animations by…
Dr Masayo Takahashi from the RIKEN center in Japan received the prestigious 2015 Ogawa-Yamanaka Prize for developing a human induced pluripotent stem (iPS) cell therapy to treat a debilitating eye…
Retinitis pigmentosa (RP) is a genetic disease that gradually destroys the light sensing nerve cells, called photoreceptors, located in the retina at the back of the eye. In this video,…
Retinitis pigmentosa (RP) is a genetic disease that gradually destroys the light sensing nerve cells, called photoreceptors, located in the retina at the back of the eye. In this video,…
Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.
